VANGL2 and breast carcinoma: Consistently, we find that Vangl2 expression is highly heterogeneous across a panel of human and murine breast cancer cell lines encompassing several molecular subtypes as well as tumors from two commonly employed genetic models of murine mammary carcinoma (Additional file 4: Fig. S1a–f).